Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease

Mov Disord. 2010 May 15;25(7):961-2; author reply 962-3. doi: 10.1002/mds.23021.
No abstract available

Publication types

  • Comment
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Glutathione / adverse effects*
  • Humans
  • Parkinson Disease / drug therapy*

Substances

  • Glutathione